«The treatment for breast cancer is currently dependent on the type of breast cancer,
defined by the estrogen receptor, progesterone receptor, and HER2 status.
Triple - negative breast cancer (TNBC), a tumor type
defined by its lack of
estrogen receptor, progesterone receptor, and Her2 (ERBB2) amplification, accounts for 16 % of breast cancers.